Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 DKK | +0.49% | -1.43% | -40.67% |
Sales 2024 * | 40M 5.74M 459M | Sales 2025 * | - | Capitalization | 471M 67.51M 5.4B |
---|---|---|---|---|---|
Net income 2024 * | -38M -5.45M -436M | Net income 2025 * | - | EV / Sales 2024 * | 11.8 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-12.4
x | P/E ratio 2025 * |
-
| Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.17% |
Latest transcript on BioPorto A/S
1 day | +0.49% | ||
1 week | -1.43% | ||
Current month | -5.20% | ||
1 month | -7.19% | ||
3 months | -41.23% | ||
6 months | -16.22% | ||
Current year | -40.67% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 17/07/13 | |
Ursula Klause
CTO | Chief Tech/Sci/R&D Officer | - | 30/11/20 |
Prasad Devarajan
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
John McDonough
CHM | Chairman | 65 | 28/04/21 |
Donnie Hardison
BRD | Director/Board Member | 74 | 28/04/21 |
Chief Executive Officer | 64 | 17/07/13 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.24 | +0.49% | 250,095 |
25/04/24 | 1.234 | +0.49% | 419,814 |
24/04/24 | 1.228 | -0.16% | 132,753 |
23/04/24 | 1.23 | +0.65% | 226,003 |
22/04/24 | 1.222 | -2.86% | 386,107 |
Delayed Quote Nasdaq Copenhagen, April 26, 2024 at 03:45 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.67% | 67.41M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- BIOPOR Stock